Zydus Lifesciences Hits 52-Week High, Receives 'Buy' Call from MarketsMOJO

Zydus Lifesciences, a leading pharmaceutical company in the largecap industry, has recently reached a new milestone. On July 29, 2024, the company's stock price hit a 52-week high of Rs.1239.7. This positive development has been recognized by MarketsMOJO, who have given a 'Buy' call for the stock. The stock has shown strong performance today, outperforming the sector by 0.45%. It has also been on a consecutive gain for the last 4 days, with a 5.86% increase in returns during this period. The stock's intraday high of Rs.1239.7 marks a 2.48% increase from the previous day's closing. Zydus Lifesciences has also displayed high volatility today, with an intraday volatility of 75.48%. This is calculated from the weighted average price, indicating a significant movement in the stock's price. In addition, the stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This further reinforces the positive trend in the stock's performance. In the past year, Zydus Lifesciences has shown an impressive growth of 89.78%, outperforming the Sensex's performance of 23.43%. This showcases the company's strong position in the market and its ability to deliver consistent returns to its investors. With its recent achievement and positive outlook, Zydus Lifesciences continues to be a promising player in the pharma industry. Investors can look forward to potential growth and returns from this largecap company.